MTM Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11M | Buy |
5,996
+1,252
| +26% | +$232K | 0.37% | 70 |
|
|
2025
Q1 | $978K | Buy |
4,744
+2
| +0% | +$412 | 0.38% | 74 |
|
|
2024
Q4 | $843K | Buy |
4,742
+3
| +0.1% | +$533 | 0.32% | 79 |
|
|
2024
Q3 | $921K | Buy |
4,739
+4
| +0.1% | +$777 | 0.36% | 73 |
|
|
2024
Q2 | $812K | Sell |
4,735
-19
| -0.4% | -$3.26K | 0.33% | 78 |
|
|
2024
Q1 | $866K | Buy |
4,754
+24
| +0.5% | +$4.37K | 0.36% | 74 |
|
|
2023
Q4 | $733K | Buy |
4,730
+2
| +0% | +$310 | 0.34% | 75 |
|
|
2023
Q3 | $705K | Buy |
4,728
+2
| +0% | +$298 | 0.36% | 76 |
|
|
2023
Q2 | $637K | Buy |
4,726
+2
| +0% | +$269 | 0.31% | 88 |
|
|
2023
Q1 | $753K | Sell |
4,724
-4
| -0.1% | -$637 | 0.39% | 75 |
|
|
2022
Q4 | $764K | Sell |
4,728
-120
| -2% | -$19.4K | 0.4% | 73 |
|
|
2022
Q3 | $651K | Buy |
4,848
+19
| +0.4% | +$2.55K | 0.37% | 77 |
|
|
2022
Q2 | $743K | Sell |
4,829
-682
| -12% | -$105K | 0.4% | 73 |
|
|
2022
Q1 | $893K | Buy |
5,511
+2
| +0% | +$324 | 0.43% | 67 |
|
|
2021
Q4 | $746K | Sell |
5,509
-198
| -3% | -$26.8K | 0.35% | 82 |
|
|
2021
Q3 | $616K | Sell |
5,707
-62
| -1% | -$6.69K | 0.33% | 87 |
|
|
2021
Q2 | $650K | Buy |
5,769
+2
| +0% | +$225 | 0.34% | 84 |
|
|
2021
Q1 | $624K | Buy |
5,767
+803
| +16% | +$86.9K | 0.35% | 81 |
|
|
2020
Q4 | $532K | Buy |
+4,964
| New | +$532K | 0.33% | 83 |
|